Company |
Drug |
Indication |
Advanced Accelerator Applications SA (Saint-Genis-Pouilly, France) |
Netspot PET diagnostic (previously Somakit-Tate) |
To identify somatostatin receptor-positive neuroendocrine tumors (NETs) in adults and pediatric patients |
Allergan plc (Dublin) |
Teflaro |
Acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia |
Allergan plc (Dublin) |
Buvalson |
Hypertension |
Allergan plc (Dublin) |
Avycaz |
Complicated intra-abdominal infections caused by designated susceptible microorganisms |
Boehringer Ingelheim Pharmaceuticals Inc. (Ridgefield, Conn.; unit of Boehringer Ingelheim GmbH and Eli Lilly and Co.) |
Jentadueto XR |
Type 2 diabetes |
Espero Pharmaceuticals Inc. (Jacksonville, Fla.) |
Gonitro |
Angina pectoris due to coronary artery disease |
Gilead Sciences Inc. (Foster City, Calif.) |
Epclusa |
Hepatitis C virus |
Intercept Pharmaceuticals Inc. (New York) |
Ocaliva |
Primary biliary cholangitis |
Opko Health Inc. (Miami) |
Rayaldee |
Secondary hyperparathyroidism |
Paxvax Inc. (Redwood City, Calif.) |
Vaxchora |
Cholera caused by serogroup O1 |
Viiv Healthcare Ltd. (London) |
Tivicay |
HIV-1 |